Literature DB >> 12620384

Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth.

Artur Schmidtchen1, Elisabet Holst, Hans Tapper, Lars Björck.   

Abstract

Leg ulcers of venous origin represent a disease affecting 0.1-0.2% of the population. It is known that almost all chronic ulcers are colonized by different bacteria, such as staphylococci, enterococci and Pseudomonas aeruginosa. We here report that P. aeruginosa, expressing the major metalloproteinase elastase, induces degradation of complement C3, various antiproteinases, kininogens, fibroblast proteins, and proteoglycans (PG) in vitro, thus mimicking proteolytic activity previously identified in chronic ulcer fluid in vivo. Elastase-producing P. aeruginosa isolates were shown to significantly degrade human wound fluid as well as human skin proteins ex vivo. Elastase-containing conditioned P. aeruginosa medium and purified elastase inhibited fibroblast cell growth. These effects, in conjunction with the finding that proteinase production was detected in wound fluid ex vivo, suggest that bacterial proteinases play a pathogenic role in chronic ulcers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620384     DOI: 10.1016/s0882-4010(02)00197-3

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  35 in total

1.  Investigating the humoral immune response in chronic venous leg ulcer patients colonised with Pseudomonas aeruginosa.

Authors:  Jasper N Jacobsen; Anders S Andersen; Michael K Sonnested; Inga Laursen; Bo Jorgensen; Karen A Krogfelt
Journal:  Int Wound J       Date:  2010-11-19       Impact factor: 3.315

2.  A fatty acid messenger is responsible for inducing dispersion in microbial biofilms.

Authors:  David G Davies; Cláudia N H Marques
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

Review 3.  Interactions between coagulation and complement--their role in inflammation.

Authors:  Katerina Oikonomopoulou; Daniel Ricklin; Peter A Ward; John D Lambris
Journal:  Semin Immunopathol       Date:  2011-08-03       Impact factor: 9.623

Review 4.  A clinical review of infected wound treatment with Vacuum Assisted Closure (V.A.C.) therapy: experience and case series.

Authors:  Allen Gabriel; Jaimie Shores; Brent Bernstein; Jean de Leon; Ravi Kamepalli; Tom Wolvos; Mona M Baharestani; Subhas Gupta
Journal:  Int Wound J       Date:  2009-10       Impact factor: 3.315

5.  Bacterial isolates from infected wounds and their antibiotic susceptibility pattern: some remarks about wound infection.

Authors:  Lucinda J Bessa; Paolo Fazii; Mara Di Giulio; Luigina Cellini
Journal:  Int Wound J       Date:  2013-02-24       Impact factor: 3.315

6.  Aspergillus fumigatus conidial metalloprotease Mep1p cleaves host complement proteins.

Authors:  Rajashri Shende; Sarah Sze Wah Wong; Srikanth Rapole; Rémi Beau; Oumaima Ibrahim-Granet; Michel Monod; Karl-Heinz Gührs; Jayanta Kumar Pal; Jean-Paul Latgé; Taruna Madan; Vishukumar Aimanianda; Arvind Sahu
Journal:  J Biol Chem       Date:  2018-08-23       Impact factor: 5.157

7.  Secretion of proteases by Pseudomonas aeruginosa biofilms exposed to ciprofloxacin.

Authors:  Ewa Ołdak; Elzbieta A Trafny
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

8.  Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection.

Authors:  George R A Cathcart; Derek Quinn; Brett Greer; Pat Harriott; John F Lynas; Brendan F Gilmore; Brian Walker
Journal:  Antimicrob Agents Chemother       Date:  2011-03-28       Impact factor: 5.191

9.  Multiple bacterial species reside in chronic wounds: a longitudinal study.

Authors:  Kristine Gjødsbøl; Jens Jørgen Christensen; Tonny Karlsmark; Bo Jørgensen; Bjarke M Klein; Karen A Krogfelt
Journal:  Int Wound J       Date:  2006-09       Impact factor: 3.315

10.  Proteolysis of human thrombin generates novel host defense peptides.

Authors:  Praveen Papareddy; Victoria Rydengård; Mukesh Pasupuleti; Björn Walse; Matthias Mörgelin; Anna Chalupka; Martin Malmsten; Artur Schmidtchen
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.